生物制药公司礼邦医药(09637.HK)公布招股详情,计划全球发售5,675.54万股H股,香港公开发售占约10%,国际配售占约90%,发售价为每股22.6元。每手买卖单位100股,入场费约2,282.79元。招股期由今日(18日)起至下周三(24日)截止,预计6月29日挂牌上市,由富瑞、美银证券及华泰国际担任联席保荐人。是次IPO共引入11名基石投资者,包括新加坡政府投资公司(GIC)、...
Source Link生物制药公司礼邦医药(09637.HK)公布招股详情,计划全球发售5,675.54万股H股,香港公开发售占约10%,国际配售占约90%,发售价为每股22.6元。每手买卖单位100股,入场费约2,282.79元。招股期由今日(18日)起至下周三(24日)截止,预计6月29日挂牌上市,由富瑞、美银证券及华泰国际担任联席保荐人。是次IPO共引入11名基石投资者,包括新加坡政府投资公司(GIC)、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.